Patents by Inventor Eric Bacque

Eric Bacque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
    Publication number: 20030153605
    Abstract: The present invention relates to the use of 2-amino-4-pyridylmethyl thiazoline derivatives of formula (I) 1
    Type: Application
    Filed: November 8, 2002
    Publication date: August 14, 2003
    Inventors: Eric Bacque, Antony Bigot, Jean-Christophe Carry, Serge Mignani, Baptiste Ronan, Michel Tabart
  • Streptogramin derivatives, their preparation and compositions containing them
    Publication number: 20030149004
    Abstract: Group A streptogramin derivatives of general formula (I) in which:
    Type: Application
    Filed: December 6, 2002
    Publication date: August 7, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Daniel Achard, Eric Bacque, Jean-Claude Barriere, Jean Bouquerel, Pascal Desmazeau, Serge Grisoni, Jean-Pierre Leconte, Yves Ribeill, Baptiste Ronan
  • Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
    Patent number: 6602884
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacqué, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stéphane Mutti, Christophe Daubié
  • Streptogramin derivatives, their preparation and compositions which contain them
    Patent number: 6596717
    Abstract: Group A streptogramin derivatives of formula (I) and salts thereof: and Group A streptogramin derivatives of formula (III) and salts thereof: as well as processes for preparing such streptogramins, and pharmaceutical compositions comprising such streptogramins, alone or combined with at least one group B streptogramin derivative.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 22, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Pascal Desmazeau, Baptiste Ronan, Eric Bacque, Jean-Claude Barriere
  • Streptogramin derivatives, their preparation and compositions containing them
    Patent number: 6569854
    Abstract: Group A streptogramin derivatives of general formula (I) in which: R1 represents a halogen atom or an azido or thiocyanato radical, R2 represents a hydrogen atom or a methyl or ethyl radical, R3 represents a hydrogen atom, or the residue of an aliphatic, cycloaliphatic, aromatic, araliphatic, heterocyclic or heterocyclylaliphatic ester which may be substituted, and the bond - - - represents a single bond (stereochemistry 27R) or a double bond, as well as its salts when they exist.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: May 27, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Eric Bacque, Jean-Claude Barriere, Jean Bouquerel, Pascal Desmazeau, Serge Grisoni, Jean-Pierre Leconte, Yves Ribeill, Baptiste Ronan
  • Streptogramin derivatives, their preparation and compositions which contain them
    Patent number: 6562852
    Abstract: Group A streptogramin derivatives of formula (I) and salts thereof: Group A streptogramin derivatives of formula (II) and salts thereof: and Group A streptogramin derivatives of formula (III) and salts thereof: as well as processes for preparing such streptogramins, and pharmaceutical compositions comprising such streptogramins, alone or combined with at least one group B streptogramin derivative.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: May 13, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Pascal Desmazeau, Baptiste Ronan, Eric Bacque, Jean-Claude Barriere
  • Streptogramin derivatives, their preparation and compositions containing them
    Patent number: 6541451
    Abstract: B-Group streptogramin compounds of formula (I): are useful as antimicrobial agents, optionally combined with at least one A-group streptogramin compound.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: April 1, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacque, Jean-Claude Barriere, Gilles Doerflinger, Gilles Dutruc-Rosset, Guy Pantel
  • 2-aminothiazoline derivatives and process for preparing the same
    Publication number: 20020198243
    Abstract: The present invention relates to a class of 2-aminothiazoline derivatives of formula I: 1
    Type: Application
    Filed: May 31, 2002
    Publication date: December 26, 2002
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Antony Bigot, Eric Bacque, Michel Tabart
  • Use of 2-aminothiazoline derivatives as inhibitors of inducible NO-synthase
    Publication number: 20020187987
    Abstract: The present invention relates to the use of 2-aminothiazoline derivatives of formula I: 1
    Type: Application
    Filed: May 31, 2002
    Publication date: December 12, 2002
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Antony Bigot, Eric Bacque, Michel Tabart
  • Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
    Publication number: 20020177606
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Application
    Filed: March 13, 2002
    Publication date: November 28, 2002
    Inventors: Eric Bacque, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stephane Mutti, Christophe Daubie
  • Streptogramin derivatives, their preparation and compositions which contain them
    Publication number: 20020156273
    Abstract: Group A streptogramin derivatives of formula (I) and salts thereof: 1
    Type: Application
    Filed: December 21, 2001
    Publication date: October 24, 2002
    Inventors: Pascal Desmazeau, Baptiste Ronan, Eric Bacque, Jean-Claude Barriere
  • Streptogramin derivatives, preparation method and compositions containing same
    Publication number: 20020151676
    Abstract: Group B streptogramin derivatives of general formula (I): 1
    Type: Application
    Filed: June 5, 2002
    Publication date: October 17, 2002
    Applicant: Aventis Pharma S.A.
    Inventors: Pascal Desmazeau, Gilles Doerflinger, Yves Ribeill, Eric Bacque, Jean-Claude Barriere, Gilles Dutruc-Rosset, Gerard Puchault
  • Streptogramin derivatives, their preparation and compositions which contain them
    Publication number: 20020143041
    Abstract: Group A streptogramin derivatives of formula (I) and salts thereof: 1
    Type: Application
    Filed: December 21, 2001
    Publication date: October 3, 2002
    Inventors: Pascal Desmazeau, Baptiste Ronan, Eric Bacque, Jean-Claude Barriere
  • Streptogramin derivatives, their preparation and compositions containing them
    Publication number: 20020132765
    Abstract: Group B streptogramin derivatives of formula (I) and salts thereof: 1
    Type: Application
    Filed: January 28, 2002
    Publication date: September 19, 2002
    Inventors: Eric Bacque, Jean-Claude Barriere, Gerard Puchault
  • Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase
    Patent number: 6451821
    Abstract: The present invention relates to the use of 2-aminothiazoline derivatives of formula: in which either R1 is a hydrogen atom or an alkyl radical and R2 is an alkyl, -alk—NH2, —CH2—R3, —CH2—S—R4 or phenyl radical substituted with a nitro or —NH— C (═NH) CH3 radical, or R1 is an alkyl radical and R2 is a hydrogen atom, R3 is a (3-6C) cycloalkyl, pyridyl, pyridyl N-oxide, thienyl, thiazolyl, imidazolyl, pyrazinyl, triazolyl or phenyl radical or a phenyl radical substituted with a nitro, hydroxy or carboxyl radical, R4 represents a pyridyl or pyridyl N-oxide radical, alk represents an alkylene radical, or pharmaceutically acceptable salts thereof, as inhibitors of inducible NO-synthase.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: September 17, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Antony Bigot, Eric Bacque, Michel Tabart
  • Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof
    Patent number: 6420566
    Abstract: The present invention relates to pharmaceutical compositions containing, as active principle, a 4,5-dihydro-1,3-thiazol-2-ylamine derivative of formula (I): in which R represents an -alk-S-alk-Ar radical, a phenyl radical or a phenyl radical substituted with alkoxy or halogen, or to one of the pharmaceutically acceptable salts thereof, to the novel derivatives of formula (I) and to their preparation.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: July 16, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Eric Bacque, Antony Bigot
  • Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase
    Publication number: 20020022631
    Abstract: The present invention relates to the use of 2-aminothiazoline derivatives of formula: 1
    Type: Application
    Filed: June 8, 2001
    Publication date: February 21, 2002
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Antony Bigot, Eric Bacque, Michel Tabart
  • Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof
    Publication number: 20020019427
    Abstract: The present invention relates to pharmaceutical compositions containing, as active principle, a 4,5-dihydro-1,3-thiazol-2-ylamine derivative of formula (I): 1
    Type: Application
    Filed: June 8, 2001
    Publication date: February 14, 2002
    Inventors: Jean-Christophe Carry, Dominique Damour, Claude Guyon, Serge Mignani, Eric Bacque, Antony Bigot
  • 5,6,7,8 tetrahydroindolizines derivatives
    Patent number: 6194426
    Abstract: A novel therapeutic use of pyrrole derivatives of the folloeing formula: in which the variables are as defined in the specification and their salts thereof for treating conditions in which TNF is involved.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: February 27, 2001
    Assignee: Rhona-Poulenc Rorer S.A.
    Inventors: Eric Bacque, Conception Nemecek, Georges Bashiardes, Norbert Dereu
  • 1,8 benzonaphthyridine derivatives and antimicrobial compositions
    Patent number: 5556861
    Abstract: This invention relates to a novel 1,8 benzo[b]naphythyridine derivative of general formula (I), ##STR1## wherein R is H or a hydroxy, amino or alkylamino radical optionally substituted by amino or hydroxy, or R is dialkylamino of which the alkyl portions may form, with the nitrogen atom, a 5- or 6-membered heterocyclic ring which optionally contains a further heteroatom chosen from nitrogen, oxygen or sulphur, or R is C.sub.3-6 cycloalkylamino or an alkanylamino, N-alkyl N-alkanylamino or aminoalkylphenylamino radical; R.sub.1 and R.sub.2, which are the same or different, are in positions 2 and 3 and represent H, alkyl, C.sub.2-4 alkenyl, phenyl, or substituted phenyl, or R.sub.1 and R.sub.2 are in position 2 and represent alkyl; R.sub.3 is H or alkyl, fluoroalkyl, carboxyalkyl, C.sub.3-6 cycloalkyl, fluorophenyl, difluorophenyl, alkyloxy or alkylamino; and R.sub.4 is H or F, wherein the C.sub.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 17, 1996
    Assignee: Laboratoire Roger Bellon
    Inventors: Eric Bacque, Michel Barreau, Jean-Francois Desconclois, Philippe Girard, Michel Kryvenko, Marc P. Lavergne, Jean-Marc Paris, Guy Picaut